/VIV.V
VIV.V Stock - Avivagen Inc.
Healthcare|Drug Manufacturers - Specialty & GenericTSXV
$0.01+100.00%
+$0.01 (+100.00%) • Feb 6
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VIV.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.00
52W High$0.10
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $939,173 | $1.30M | $1.18M | $977,451 | $1.07M |
| Gross Profit | $400,299 | $534,340 | $470,980 | $526,481 | $653,737 |
| Gross Margin | 42.6% | 41.2% | 40.0% | 53.9% | 61.0% |
| Operating Income | $-933,530 | $-4,808,129 | $-3,536,047 | $-4,110,362 | $-4,534,883 |
| Net Income | $-6,066,206 | $-6,394,159 | $-4,751,287 | $-4,836,420 | $-4,834,059 |
| Net Margin | -645.9% | -493.4% | -403.4% | -494.8% | -450.7% |
| EPS | $-0.09 | $-0.12 | $-0.12 | $-0.14 | $-0.15 |
Company Overview
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VIV.VBeat Rate
0%
Last 13 quarters
Avg Surprise
-21.4%
EPS vs Estimate
Beats / Misses
0/8
5 met exactly
Latest EPS
$-0.01
Q3 2023
EPS Surprise History
Q1 22
0.0%
$-0.02vs$-0.02
Q1 22
-20.0%
$-0.03vs$-0.03
Q2 22
-20.0%
$-0.02vs$-0.02
Q3 22
-20.0%
$-0.03vs$-0.03
Q1 23
-49.9%
$-0.01vs$-0.01
Q1 23
No data
Q2 23
No data
Q3 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Sep 26, 2024 | — | — | — | — |
Q2 2024 | Jun 14, 2024 | — | — | — | — |
Q2 2024 | Apr 29, 2024 | — | — | — | — |
Q1 2024 | Jan 3, 2024 | — | — | — | — |
Q3 2023 | Sep 28, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 6, 2023 | — | $-0.02 | — | — |
Q1 2023 | Mar 16, 2023 | — | $-0.01 | — | — |
Q1 2023 | Feb 21, 2023 | $-0.01 | $-0.01 | -49.9% | ✗ MISS |
Q3 2022 | Sep 16, 2022 | $-0.03 | $-0.03 | -20.0% | ✗ MISS |
Q2 2022 | Jun 15, 2022 | $-0.02 | $-0.02 | -20.0% | ✗ MISS |
Q1 2022 | Mar 30, 2022 | $-0.03 | $-0.03 | -20.0% | ✗ MISS |
Q1 2022 | Jan 19, 2022 | $-0.02 | $-0.02 | 0.0% | = MET |
Q3 2021 | Sep 28, 2021 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q2 2021 | Jun 2, 2021 | $-0.03 | $-0.04 | -60.0% | ✗ MISS |
Q1 2021 | Mar 3, 2021 | $-0.03 | $-0.03 | 0.0% | = MET |
Q4 2020 | Dec 15, 2020 | $-0.03 | $-0.03 | 0.0% | = MET |
Q3 2020 | Sep 2, 2020 | $-0.01 | $-0.02 | -33.3% | ✗ MISS |
Q2 2020 | Jun 2, 2020 | $-0.03 | $-0.03 | 0.0% | = MET |
Q1 2020 | Mar 4, 2020 | $-0.04 | $-0.04 | 0.0% | = MET |
Q4 2019 | Dec 19, 2019 | $-0.02 | $-0.03 | -25.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about VIV.V
What is VIV.V's current stock price?
Avivagen Inc. (VIV.V) is currently trading at $0.01 per share. The stock has moved +100.00% today.
What is the analyst price target for VIV.V?
No analyst price targets are currently available for this stock.
What sector is Avivagen Inc. in?
Avivagen Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the TSXV exchange.
What is VIV.V's market cap?
Avivagen Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does VIV.V pay dividends?
No, Avivagen Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAQS.V
Aequus Pharmaceuticals Inc.
$0.01
Mkt Cap: $0.0B
GNOM.CN
Gnomestar Craft Inc.
$0.01
Mkt Cap: $0.0B
GSL.CN
Green Scientific Labs Holdings Inc.
$0.06
Mkt Cap: $0.0B
HMPS.CN
Hempsana Holdings Ltd.
$0.01
Mkt Cap: $0.0B
IBH.CN
Indigenous Bloom Hemp Corp.
$0.01
Mkt Cap: $0.0B
IONC.CN
Ionic Brands Corp.
$0.01
Mkt Cap: $0.0B
MEDV.NE
Medivolve Inc.
$0.03
Mkt Cap: $0.0B
MJ.CN
Maven Brands Inc.
$0.02
Mkt Cap: $0.0B
MPXI.CN
MPX International Corporation
$0.01
Mkt Cap: $0.0B
NHP.V
Lumiera Health Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to VIV.V for comparison